Transforming screening
and management of
diabetic eye disease.

Asset 11_4x.png
GreyWorldMap-07.jpg

GLOBAL DIABETES

1in3-07.jpg

51% projected increase in global diabetes
by 2045

1 out of 3
diabetic patients develop diabetic retinopathy

500 million adults suffer from diabetes worldwide

UpwardArrow-07_edited_edited.png

WHAT WE DO

Early Detection

Oivi’s product and service allows for early detection of diabetic retinopathy; reducing the number of people who suffer permanent loss of vision.

Asset 10_4x.png

Point-of-need Care

Oivi enables diagnosis at the

point-of-need, reaching high-risk

diabetic patients right where ever

they may be located.

Rapid Diagnosis

Oivi drastically reduces time to

diagnosis, our intelligent camera and seamless service model shortens

time to treatment thereby reducing costs

for both patients and healthcare systems.

Asset 11_4x.png

Expanding screening for eye diseases from
specialist clinics to primary care clinics

Asset 31_4x.png

PRIMARY CARE CENTRES

DIABETES CLINICS

PHARMACIES

EYE HOSPITALS

Asset 32_4x.png
Asset 33_4x.png
Asset 35_4x.png
Asset 11_4x_edited.png

OUR SUPPORT

NicePng_extreme-png_9764918_edited.png
61284_web-2_edited_edited.jpg
Logo_of_L._V._Prasad_Eye_Institute.jpg
logoSINTEF_edited.png
orglogo_edited.jpg
st-johns-medical-college-hospital_edited

THE TEAM

Anders.jpg

Anders Eikenes

CEO & CO-FOUNDER

khaleel-Oivi_edited.jpg

Khaleel Udyawar

CTO & CO-FOUNDER

jukka.jpg

Jukka Alasirnio

COO & CO-FOUNDER

Find out more about Oivi

Asset 11_4x_edited.png